FDA Says Ranbaxy Falsified Data From India Plant
The U.S. Food and Drug Administration has accused a Ranbaxy Laboratories Ltd. facility in India of submitting false information and test results for certain approved drugs and pending drug applications....To view the full article, register now.
Already a subscriber? Click here to view full article